SeaCrest Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-7,396	Closed	-$615K	–	656
2023 Q2	$615K	Sell	7,396 -3,168	-30%	-$265K	0.08%	270
2023 Q1	$805K	Buy	10,564 +273	+3%	+$22.7K	0.11%	209
2022 Q4	$854K	Buy	+10,291	New	+$833K	0.12%	191
2022 Q3	–	Sell	-1,283	Closed	-$95K	–	1546
2022 Q2	$95K	Buy	+1,283	New	+$96.3K	0.01%	883
2021 Q4	–	Sell	-1,778	Closed	-$224K	–	735
2021 Q3	$224K	Buy	1,778 +100	+6%	+$12.9K	0.03%	591
2021 Q2	$227K	Sell	1,678 -100	-6%	-$13.1K	0.03%	605
2021 Q1	$241K	Hold	1,778	–	–	0.03%	537
2020 Q4	$250K	Buy	+1,778	New	+$228K	0.04%	494
2019 Q2	–	Sell	-2,060	Closed	-$187K	–	1865
2019 Q1	$187K	Buy	2,060 +560	+37%	+$47.6K	0.03%	497
2018 Q4	$108K	Sell	1,500 -560	-27%	-$45.1K	0.02%	638
2018 Q3	$197K	Buy	2,060 +100	+5%	+$9.7K	0.03%	505
2018 Q2	$187K	Hold	1,960	–	–	0.03%	515
2018 Q1	$172K	Buy	1,960 +240	+14%	+$21.9K	0.03%	529
2017 Q4	$146K	Buy	+1,720	New	+$144K	0.03%	588